Suppr超能文献

重组人生长激素(rhGH)治疗后发生的糖尿病

Diabetes mellitus after therapy with recombinant human growth hormone (rhGH).

作者信息

Stefanidis C J, Papathanassiou A, Michelis K, Theodoridis X, Papachristou F, Sotiriou J

机构信息

A Kyriakou Children's Hospital, Athens, Greece.

出版信息

Br J Clin Pract Suppl. 1996 Aug;85:66-7.

PMID:8995038
Abstract

An eight-year-old boy developed diabetes mellitus (DM) after kidney transplantation. This boy had previously been treated with recombinant human growth hormone (rhGH) for short stature due to chronic renal failure. An impaired glucose tolerance was documented after one year of rhGH treatment. An oral glucose tolerance test returned to normal six months after the discontinuation of rhGH. The boy was treated again with rhGH for seven months until his transplantation. A high fever with an enlargement of the parotid gland was noted and signs of acute rejection appeared two weeks post-transplantation. Two months after transplantation, overt DM had developed, and he was treated with insulin. The insulin dose was progressively decreased and was discontinued eight months after transplantation.

摘要

一名八岁男孩在肾移植后患上了糖尿病。该男孩此前因慢性肾衰竭身材矮小,接受过重组人生长激素(rhGH)治疗。rhGH治疗一年后记录到糖耐量受损。停用rhGH六个月后口服葡萄糖耐量试验恢复正常。该男孩在移植前再次接受了七个月的rhGH治疗。移植后两周出现高热伴腮腺肿大以及急性排斥反应迹象。移植后两个月,明显的糖尿病已发展,他接受了胰岛素治疗。胰岛素剂量逐渐减少,移植后八个月停药。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验